Skip to main
APRE
APRE logo

Aprea Therapeutics (APRE) Earnings Dates & Reports

Aprea Therapeutics (APRE) Most Recent Earnings

Report DateMar 25, 2025
Period EndingQ4 2024
Est. EPS-$0.68
Actual EPS-$0.49
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Aprea Therapeutics (APRE) Earnings per Share (EPS) History

Signup for full access
Browse free

Aprea Therapeutics (APRE) Latest Earnings

The value each APRE share was expected to gain vs. the value each share gained.

Aprea Therapeutics (APRE) reported its most recent earnings on Mar 25, 2025 for Q4 2024, posting earnings per share (EPS) of -$0.49. This exceeded analysts' expectations of -$0.68 by 27.94%, marking a Beat.

For comparison, Aprea Therapeutics reported EPS of -$0.92 in the same quarter last year.

The company is expected to announce its next earnings report on 08/11/2025, with analysts projecting an EPS of $0.

Aprea Therapeutics (APRE) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Aug 11, 2025
Next earnings call Aug. 11, 2025
Q1 2025May 14, 2025
-$0.66
DeckReportListen
Q4 2024Mar 25, 2025
-$0.68-$0.49-27.94%
Q3 2024Nov 7, 2024
-$0.72-$0.64-11.11%
Q2 2024Aug 12, 2024
-$0.64-$0.58-9.38%
View all

Aprea Therapeutics (APRE) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Aprea Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 14, 2025
Mar 25, 2025
Nov 7, 2024
Aug 12, 2024

Aprea Therapeutics (APRE) Earnings FAQs

Aprea Therapeutics (APRE) last reported earnings on Mar 25, 2025 for Q4 2024, posting an EPS of -$0.49, which Beat the estimate of -$0.68 by 27.94%.

For Q4 2024, Aprea Therapeutics (APRE) reported an EPS of -$0.49, exceeding analysts' estimate of -$0.68 by 27.94%.

For Q4 2024, Aprea Therapeutics (APRE) Beat expectations with an actual EPS of -$0.49 vs. an estimated EPS of -$0.68.

Following the last earnings report on Mar 25, 2025, Aprea Therapeutics (APRE)'s stock price moved — from — to —.

The next Aprea Therapeutics (APRE) earnings call is scheduled for Aug. 11, 2025, where executives will discuss financial results and outlook.

Aprea Therapeutics (APRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.